Home

elpirul Amikor Tisztességtelenség magl inhibitor clinical trial friss Lakó zsidó

Pharmaceuticals | Free Full-Text | Potential of Fatty Acid Amide Hydrolase  (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL)  Enzymes as Targets for Obesity Treatment: A Narrative Review
Pharmaceuticals | Free Full-Text | Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review

Potential application of endocannabinoid system agents in neuropsychiatric  and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta  Pharmacologica Sinica
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica

Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New  Targets for Future Antidepressants | Bentham Science
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants | Bentham Science

The highs of endocannabinoid physiology - The Physiological Society
The highs of endocannabinoid physiology - The Physiological Society

Synthesis and Preclinical Evaluation of Sulfonamido-based  [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase
Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase

Frontiers | Discovering monoacylglycerol lipase inhibitors by a combination  of fluorogenic substrate assay and activity-based protein profiling
Frontiers | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling

Monoacylglycerol lipase (MAGL) as a promising therapeutic target -  ScienceDirect
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect

Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit  of Therapies for Neurological and Neurodegenerative Diseases
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases

A Schematic model of the effects of MAGL inhibition on the interactions...  | Download Scientific Diagram
A Schematic model of the effects of MAGL inhibition on the interactions... | Download Scientific Diagram

APExBIO - MJN110 | MAGL inhibitor | CAS# 1438416-21-7
APExBIO - MJN110 | MAGL inhibitor | CAS# 1438416-21-7

Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol  Lipase and Clinical Candidate for Treatment of Neurological Disorders |  Journal of Medicinal Chemistry
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders | Journal of Medicinal Chemistry

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect

A potent and selective inhibitor for the modulation of MAGL activity in the  neurovasculature | PLOS ONE
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature | PLOS ONE

Figure 5 from Chemical approaches to therapeutically target the metabolism  and signaling of the endocannabinoid 2-AG and eicosanoids. | Semantic  Scholar
Figure 5 from Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. | Semantic Scholar

Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit  of Therapies for Neurological and Neurodegenerative Diseases
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases

A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates  Multiple Sclerosis - Hernández‐Torres - 2014 - Angewandte Chemie  International Edition - Wiley Online Library
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis - Hernández‐Torres - 2014 - Angewandte Chemie International Edition - Wiley Online Library

Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). |  Download Scientific Diagram
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram

Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit  of Therapies for Neurological and Neurodegenerative Diseases
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases

Figure 1 from Chemical approaches to therapeutically target the metabolism  and signaling of the endocannabinoid 2-AG and eicosanoids. | Semantic  Scholar
Figure 1 from Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. | Semantic Scholar

Frontiers | Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal  Hyperexcitability, Restores Dendritic Arborization Complexity, and  Regulates Reward-Related Behavior in Presence of HIV-1 Tat
Frontiers | Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat

APExBIO - Monoacylglycerol Lipase Inhibitor 21 inhibitor of  monoacylglycerol lipase (MAGL) and FAAH | CAS# 1643657-35-5
APExBIO - Monoacylglycerol Lipase Inhibitor 21 inhibitor of monoacylglycerol lipase (MAGL) and FAAH | CAS# 1643657-35-5

Therapeutic endocannabinoid augmentation for mood and anxiety disorders:  comparative profiling of FAAH, MAGL and dual inhibitors | Translational  Psychiatry
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors | Translational Psychiatry

Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on  bone remodelling in healthy and cancer-bearing mice - eBioMedicine
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - eBioMedicine

Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective  Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of  Neuroinflammation | Journal of Medicinal Chemistry
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation | Journal of Medicinal Chemistry

Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). |  Download Scientific Diagram
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram

Synthesis and biological evaluation of novel tanshinone IIA derivatives for  treating pain
Synthesis and biological evaluation of novel tanshinone IIA derivatives for treating pain

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective  Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of  Neuroinflammation | Journal of Medicinal Chemistry
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation | Journal of Medicinal Chemistry

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect